Beryl Capital Management LLC - Dec 30, 2024 Form SCHEDULE 13G Schedule Report for Marinus Pharmaceuticals, Inc. (MRNS)

Filing Manager
Beryl Capital Management LLC
Reporting Manager
Beryl Capital Management LLC
Security
Marinus Pharmaceuticals, Inc. Common Stock
Symbol
MRNS
Shares outstanding
55.2M shares
Disclosed Ownership
5.46M shares
Ownership
9.9%
Form type
SCHEDULE 13G
Date filed
1/7/2025, 07:15 PM
Date of event
Dec 30, 2024
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Beryl Capital Management LLC 9.9% 5.46M 0 5.46M /s/ Andrew Nelson Chief Operating Officer
Beryl Capital Management LP 9.9% 5.46M 0 5.46M /s/ Andrew Nelson Chief Operating Officer of Beryl Capital Management LLC, General Partner of Beryl Capital Management LP
Beryl Capital Partners II LP 8.7% 4.8M 0 4.8M /s/ Andrew Nelson Chief Operating Officer of Beryl Capital Management LLC, General Partner of Beryl Capital Management LP, General Partner of Beryl Capital Partners II
David A. Witkin 9.9% 5.46M 0 5.46M /s/ David A. Witkin Reporting person